comic labonfoil
Post on 10-May-2015
763 Views
Preview:
DESCRIPTION
TRANSCRIPT
LABONFOILLaboratory Skin Patches and SmartCards based on foils and compatible with aSmartbiophone.
INSTRUMENT: Large-scale integrating project (IP)
LABONFOIL
Contract no. 224306
Due Date of Deliverable: 1-7-2008Completion Date of Deliverable: 28-9-2008
Start date of project: 1-5-2008 Duration: 31-4-2012
Responsible partner for deliverable: IKERLAN Revision: v3.1
Project co-funded by the European Commission within the 7th Framework Programme
Dissemination Level
PU Public ✘PP Restricted to other programme participants (including the Commission Services)
RE Restricted to a group specified by the consortium (including Commission Services)
CO Confidential, only for members of the consortium (including Commission Services)
D2.3 Scenarios of Labcard and Skin Patch
1 1
1 2
1 3
1 4
2 1
2 2
2 3
2 4
3 1
3 2
3 3
3 4
4 1
4 2
4 3
4 4
VisionPortable diagnostic tools are urgently required to ensure rapid,affordable and simple analysis in many scenarios that willbenefit our society (e.g. in; hospitals, airports, doctor’s practice,roadside police controls, natural environment).
However, conventional analytical methods often require a largevolume of sample and complicated time-consuming protocols.Current portable devices are based on less sensitive immunoch-romatographic strips or electrochemical detection systems, whe-reas desktop systems (though sensitive and semi-automatic) arebulky and heavy.
StrategyDue to the biomicrofabrication results achieved within the
consortium and remarkable synergy with organic
optoelectronics, lamination and biological reactions,
the consortium can now seize the opportunity to
develop a fully integrated device with ultra-low cost.
The combination of these technologies will produce a
successful portable diagnostic device able to analyse all major
biomolecule classes (proteins, RNA and DNA) in a wide range of
applications.
The new testing devices will consist of a lab-on-a-chip (LOC)
embedded in a smartcard or a skin patch. The Labcard and Skin
Patch components will be manufactured using a reel-to-reel
system radically decreasing the price to 1% of existing systems
(wafer based).
LABONFOILLABONFOIL
The future mass production of these novel diagnostic components
will be guaranteed by the development of manufacturing
equipment. This will provide, at last, a standardised solution to
manufacture truly ultra-low-cost Lab-on-a-chip microsystems. The
dramatic cost reduction will be based on the use of large films
instead of wafer substrates. The smart mobile phone will offer
a vast range of straightforward communication and interface
capabilities. This strategy will turn a smartphone into a portable
diagnostic device. The Labcards and the skin patches will
demonstrate the wide range of applications and the potential of
the technology.
ObjectivesThe objective of the LabOnFoil project is to develop ultra-low-cost
laboratories on chips (LOC) without compromising time
response, sensitivity or simplicity of use. The user will obtain
the test results using a very popular interface (a smartphone)
and a set of Labcards and skin patches, where the sample prepa-
ration and detection take place. The project will validate the
devices in four applications:
• Labcard for marine algae analyisis, climate change, CO2sequestration, and toxic blooms.
• Labcard for Salmonella spp. and Campylobacter spp. detectionin slaughter houses and farms.
• Labcard for Colorectal Cancer monitoring using blood.
• Skin patch for cocaine consumption testing of professionaldrivers.
Project Partners
● IKERLAN-IK4, S.Coop. (Project Coordinator)–Spain–
● GAIKER-IK4 Technological Centre–Spain–
● University Of Southampton–United Kingdom–
● Natural Environment Research Council–United Kingdom–
● Dep. Micro and Nanotechnology (Danmarks Tekniske Universitet)–Denmark–
● National Veterinary Institute (Danmarks Tekniske Universitet)–Denmark–
● Fundación Vasca De Innovación E Investigación Sanitarias–Spain–
● Politechnika Wroclawska–Poland–
● Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.–Germany–
● Biosensia Limited–Ireland–
● TATAA Biocenter AB–Sweden–
● EVGroup E. Thallner Gmbh–Austria–
● Biotools Biotechnological & Medical Laboratories S.A.–Spain–
● Micro Resist Technology–Germany–
● Gema Medical S.L.–Spain–
Deliverable objective
The purpose of the diffusion of these four stories is to obtain a feedback from interested people who read it. Feel free to contactus or send us your opinion about the envisioned device and its applications. It would be highly appreciated.
Contact
Jesús M. Ruano-LópezIKERLAN-IK4, S.Coop.J.Mª Arizmendarrieta, N. 220500 Arrasate-MondragónSPAINe-mail: jmruano@ikerlan.eswww.ikerlan.esWeb site: www.labonfoil.euTimeline: Start: 01-05-08
End: 30-04-12Budget: Overall Cost: 7.097.808 €
EC Funding: 5.300.000 €
Contract number: 224306 Supported by FP7
ww
w.la
bo
nfo
il.eu
top related